Ann: Admedus to showcase CardioCel at EACTS Annual Meeting, page-27

400 open heart reconstructive procedures on paediatric patients in this facility. seems to be in line with the findings from other facilities, of 350 procedures per year at the Monroe Carell Jr Childrens hospital at Vanderbilt, Nashville, and, the same at the Queensland Paediatric Cardiac Services (Mater Childrens Hospital Brisbane - previously known as the Prince Charles Hospital).

It seems that paediatric centres that perform reconstructive cardiac surgery on children all do so at a similar rate - 300 - 400+ cases per year, be the location London, Nashville or good old Brisvagas.

More pieces of the puzzle to guestimate the potential market size.

Quick calculation...........350 (number of annual cases) x 0.5 (only half of procedures require a patch apparently) x $1500 = $2.625 000. With the 20 ish facilities currently using cardiocel, if these figures are remotely an accurate reflection.........the annual income is potentially 53 million.

That is the limited number of facilities we currently have with 100% uptake of the product - which is not completely outside of the realm of possibility.

multiply this by 7.5 for the medium term target of 150 facilities............and it is a few bucks short of 400 million.

All looks good in theory